Company News
Archit Organosys Preferential Issue for Archit Life Science Acquisition
Archit Organosys proposes preferential allotment of 3.72 crore shares at ₹65 each to acquire 92.20% stake in Archit Life Science Limited.
FY26 financial performance showed 11.77% revenue growth to ₹14
